MARKET

RAJAF

RAJAF

Tfa Therapeutics Inc
OTCMQB
3.010
NaN%
Closed 09:30 10/30 EDT
OPEN
--
PREV CLOSE
3.010
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
9.22
52 WEEK LOW
0.665
MARKET CAP
334.47M
P/E (TTM)
-2150.0000
1D
5D
1M
3M
1Y
5Y
1D
No Data
About RAJAF
TFA Therapeutics, Inc., formerly Cordyceps Sunshine Biotech Holdings Co., Ltd., is a company mainly engaged in the research and development of novel nonsteroidal anti-inflammatory drugs. The Company uses antrocin A as its core candidate molecule to develop anti-inflammatory drugs with steroid replacement potential. Its main research project is TFA-01, currently targeting canine osteoarthritis as its primary indication, with plans to subsequently evaluate its applications in feline chronic dentistry and dermatitis. The Company has also established a bacterial strain development, culture amplification, and related technology platform to support the research and development of its candidate drugs.

Webull offers Cordyceps Sunshine Biotech Hldngs Co Ltd stock information, including OTCMQB: RAJAF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RAJAF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RAJAF stock methods without spending real money on the virtual paper trading platform.